Cryo Cell International (CCEL) EBITDA Margin (2010 - 2026)
Cryo Cell International (CCEL) posted quarterly EBITDA Margin of 15.4% for Q2 2026, down 343.0% year-over-year from 6.34% in Q2 2025, and up 54.62% quarter-over-quarter from 9.96% in Q1 2026.
Cryo Cell International (CCEL) EBITDA Margin (2010 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported EBITDA Margin for 17 consecutive years, with 15.4% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA Margin fell 343.0% year-over-year to 15.4%; the TTM figure through May 2026 stood at 0.33% (down 1226.0% YoY), while the FY2025 annual figure was 1.53%, down 935.0% from the prior year.
- EBITDA Margin improved to 15.4% in Q2 2026 per CCEL's latest filing, from 9.96% in the prior quarter.
- Across five years, EBITDA Margin topped out at 24.29% in Q3 2025 and bottomed at 205.37% in Q4 2023.
- Historically, EBITDA Margin has averaged 1.54% across 5 years, with a median of 14.0% in 2023.
- Annual changes were most pronounced in 2023 — EBITDA Margin tumbled 21059 bps — and 2024, when it soared 20384 bps.
- Cryo Cell International's EBITDA Margin stood at 5.22% in 2022, then plunged by 4033 bps to 205.37% in 2023, then surged by 99 bps to 1.52% in 2024, then plunged by 3217 bps to 50.58% in 2025, then jumped by 130 bps to 15.4% in 2026.
- Business Quant data shows CCEL's EBITDA Margin at 15.4% in Q2 2026, 9.96% in Q1 2026, and 50.58% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -12.60% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 26.67% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 2.10% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 16.29% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 8.50% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 11.14% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 7.66% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 13.25% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 18.99% |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn | 15.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 15.40% |
| Feb 28, 2026 | 9.96% |
| Nov 30, 2025 | -50.58% |
| Aug 31, 2025 | 24.29% |
| May 31, 2025 | 18.83% |
| Feb 28, 2025 | 13.25% |
| Nov 30, 2024 | -1.52% |
| Aug 31, 2024 | 17.23% |
| May 31, 2024 | 17.30% |
| Feb 29, 2024 | 10.46% |
| Nov 30, 2023 | -205.37% |
| Aug 31, 2023 | 14.75% |
| May 31, 2023 | 13.22% |
| Feb 28, 2023 | 21.51% |
| Nov 30, 2022 | 5.22% |
| Aug 31, 2022 | 12.42% |
| May 31, 2022 | 15.65% |
| Feb 28, 2022 | 20.26% |
| Nov 30, 2021 | -11.05% |
| Aug 31, 2021 | 21.27% |